Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arrhythmia Research Technology Inc Appoints Michael Gunter as Interim Chief Executive Officer

Tuesday, 30 Oct 2012 02:40pm EDT 

Arrhythmia Research Technology Inc announced the appointment of Michael S. Gunter, a director, as interim Chief Executive Officer upon the resignation of James E. Rouse as the Company's Chief Executive Officer and as a member of its Board of Directors effective October 26, 2012. 

Company Quote

0.02 +0.28%
19 Sep 2014